Patient demographics and baseline disease characteristics
| Patient characteristic | Number of patients (n = 89; %) |
|---|---|
| Age (y) | |
| Median (range) | 67 (46–80) |
| Gender | |
| Male | 69 (78) |
| Female | 20 (22) |
| Race | |
| White | 79 (89) |
| African American | 2 (2) |
| Other | 6 (X) |
| Asian | 2 (2) |
| KPS | |
| 100 | 22 (24.7) |
| 90 | 40 (44.9) |
| 80 | 21 (23.6) |
| 70 | 6 (6.7) |
| Stage of disease | |
| IV | 43 (48) |
| III | 35 (39) |
| II | 5 (6) |
| IB | 4 (5) |
| IA | 2 (2) |
| Histology | |
| Epithelial | 79 (88.8) |
| Mixed | 10 (11.2) |
| Exposure to asbestos | |
| Yes | 56 (62.9) |
| No | 20 (22.5) |
| Unknown | 13 (14.6) |
| EORTC prognostic score | |
| Low-risk | 25 (28.1) |
| High-risk | 64 (71.9) |
| Smoking history | |
| Yes | 58 (65.2) |
| No | 31 (34.8) |
Abbreviations: EORTC, European Organization for Research and Treatment of Cancer; KPS, Karnofsky Performance Status.